Ines Barthelemy
Univ. Paris Est Créteil, INSERM U955 IMRB, EFS, IMRB, Team BNMS
Maisons-les-soulaines, France
Maisons-les-soulaines, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy.
Journal: Science advances
Published: October 22, 2025
Is Fentanyl Rebound an Intrinsic Feature of Naloxone Reversal?
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 04, 2025
Exploring Desmin as a Potential Modifier in Duchenne Muscular Dystrophy-Associated Cardiomyopathy.
Journal: Acta physiologica (Oxford, England)
Published: June 01, 2025
Early Endosome Disturbance and Endolysosomal Pathway Dysfunction in Duchenne Muscular Dystrophy.
Journal: The American journal of pathology
Published: January 10, 2025
Ambulatory electrocardiographic longitudinal monitoring in a canine model for Duchenne muscular dystrophy identifies decreased very low frequency power as a hallmark of impaired heart rate variability.
Journal: Scientific reports
Published: December 28, 2023
Spatial and Temporal Non-Uniform Changes in Left Ventricular Myocardial Strain in Dogs with Duchenne Muscular Dystrophy.
Journal: Journal of cardiovascular development and disease
Published: March 15, 2023
Canine Model of Human Frailty: Adaptation of a Frailty Phenotype in Older Dogs.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: September 19, 2022
Receptor interacting protein kinase-3 mediates both myopathy and cardiomyopathy in preclinical animal models of Duchenne muscular dystrophy.
Journal: Journal of cachexia, sarcopenia and muscle
Published: September 06, 2022
A dog model for centronuclear myopathy carrying the most common DNM2 mutation.
Journal: Disease models & mechanisms
Published: July 28, 2021
Last Updated: 09/26/2026